Competitors have taken their drugs also a lot further down the clinical testing road. Unfortunately so far, they all seem not to work. At this stage 2-73 seems to do something to make life easier for 32 Australian persons.
We need to expand the participants pool and get a lot more data before we can claim to have a blockbuster.
I do recognize we have world experts in their respective fields on our SAB. But honestly, even if we have the Queen, or the President, or Mohammed, or the Shah, or Marie Curie on our board, the drug is gonna work or it will not work.
So far, I am trying to retain a healthy skeptical view. I believe this is the most sensible investor approach until we have more scientific confirmation of the initial results